Tomasz Kos, PhD
Affiliations: | Behavioral Neuroscience | Institute of Pharmacology, Polish Academy of Sciences |
Area:
neuroscience, behavioral neuropharmacology, antidepressant pharmacology, rodent behavior, learning and memory, animal models of psychiatric disordersGoogle:
"Tomasz Kos"Mean distance: 18.66 (cluster 48) | S | N | B | C | P |
Parents
Sign in to add mentor| Piotr Popik | grad student | 2003- | Institute of Pharmacology, Polish Academy of Sciences |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Matloka M, Janowska S, Pankiewicz P, et al. (2022) A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects. Frontiers in Pharmacology. 13: 999685 |
| Zajdel P, Grychowska K, Mogilski S, et al. (2021) Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT and 5-HT Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry |
| Kozela E, Krawczyk M, Kos T, et al. (2019) Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Molecular Neurobiology |
| Zajdel P, Kos T, Marciniec K, et al. (2018) Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. European Journal of Medicinal Chemistry. 145: 790-804 |
| Vanda D, Soural M, Canale V, et al. (2017) Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties. European Journal of Medicinal Chemistry. 144: 716-729 |
| Popik P, Hołuj M, Kos T, et al. (2017) Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents. Neurotoxicity Research |
| Zurawek D, Salerno-Kochan A, Dziedzicka-Wasylewska M, et al. (2017) Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia. Schizophrenia Research |
| Canale V, Partyka A, Kurczab R, et al. (2017) Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Bioorganic & Medicinal Chemistry |
| Cieślak PE, Llamosas N, Kos T, et al. (2017) The role of NMDA receptor-dependent activity of noradrenergic neurons in attention, impulsivity and exploratory behaviors. Genes, Brain, and Behavior |
| Potasiewicz A, Hołuj M, Kos T, et al. (2016) 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology |